Final answer:
If a client develops malignant hyperthermia while receiving succinylcholine during a surgical procedure, the nurse should stop the administration of succinylcholine and administer dantrolene, the specific antidote. Supportive care should also be provided.
Step-by-step explanation:
If a client develops malignant hyperthermia while receiving succinylcholine during a surgical procedure, the nurse should take the following actions:
- Stop administration of succinylcholine immediately.
- Administer dantrolene, which is the specific antidote for malignant hyperthermia. Dantrolene works by inhibiting calcium release from the sarcoplasmic reticulum, which helps to reduce muscle contractions, hyperthermia, and acidosis associated with malignant hyperthermia.
- Provide supportive care such as cooling measures, intravenous fluids, and monitoring of vital signs.
It is important for the nurse to be alert for signs and symptoms of malignant hyperthermia, such as rapid rise in body temperature, tachycardia, muscle rigidity, and elevated carbon dioxide levels. Swift intervention is crucial to prevent serious complications.